Lexeo Therapeutics
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy (NCT07721025) | Lexeo Therapeutics | 2026-06-25 |
| Clinical Course Of Disease In Participants With FA-CM (NCT06865482) | Lexeo Therapeutics | 2025-09-30 |
| Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant (NCT07050160) | Lexeo Therapeutics | 2025-08-29 |
| Gene Therapy for ACM Due to a PKP2 Pathogenic Variant (NCT06109181) | Lexeo Therapeutics | 2024-02-29 |
| A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM (NCT06976606) | Lexeo Therapeutics | 2024-01-23 |
| Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease (NCT05400330) | Lexeo Therapeutics | 2023-05-08 |
| Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia (NCT05445323) | Lexeo Therapeutics | 2022-08-24 |
| Gene Therapy for APOE4 Homozygote of Alzheimer's Disease (NCT03634007) | Lexeo Therapeutics | 2019-11-06 |
Track Lexeo Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.